Citigroup Inc Deciphera Pharmaceuticals, Inc. Transaction History

Citigroup Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$13.58 - $17.36 $1.76 Million - $2.24 Million	129,269 Added 206.57%	191,849 $3.02 Million
Q4 2023 Feb 09, 2024	BUY	$10.11 - $16.54 $20,220 - $33,080	2,000 Added 3.3%	62,580 $1.01 Million
Q3 2023 Nov 09, 2023	SELL	$12.46 - $15.48 $323,249 - $401,597	-25,943 Reduced 29.98%	60,580 $770,000
Q2 2023 Aug 10, 2023	SELL	$13.28 - $15.96 $1.4 Million - $1.68 Million	-105,281 Reduced 54.89%	86,523 $1.22 Million
Q1 2023 May 11, 2023	BUY	$14.26 - $22.1 $1.13 Million - $1.75 Million	79,398 Added 70.64%	191,804 $2.96 Million
Q4 2022 Feb 09, 2023	SELL	$14.85 - $19.04 $1.13 Million - $1.44 Million	-75,812 Reduced 40.28%	112,406 $1.84 Million
Q3 2022 Nov 10, 2022	BUY	$12.38 - $20.23 $292,898 - $478,621	23,659 Added 14.38%	188,218 $3.48 Million
Q2 2022 Aug 10, 2022	BUY	$9.11 - $13.98 $857,241 - $1.32 Million	94,099 Added 133.55%	164,559 $2.17 Million
Q1 2022 May 12, 2022	SELL	$6.87 - $11.11 $2.4 Million - $3.88 Million	-349,257 Reduced 83.21%	70,460 $653,000
Q4 2021 Feb 10, 2022	BUY	$7.7 - $37.13 $2.6 Million - $12.6 Million	338,209 Added 414.94%	419,717 $4.1 Million
Q3 2021 Nov 10, 2021	BUY	$26.46 - $37.15 $2.16 Million - $3.03 Million	81,508 New	81,508 $2.77 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.